Inventor · disambiguated record
Nanxin Li
Also filed as: LI NANXIN
2 granted patents·8 pending applications·1 citations·filing 2012–2023
29Inventor score
Files withGUANGDONG NEWOPP BIOPHARMACEUTICALS CO LTD4NOVARTIS AG3ADVENT PHARMA CO LTD1LI NANXIN1PANTANO SERAFINO1
Top patents by PatentIndex Score
10 records- 0158US11655260B2Heterocyclic compounds as arginase inhibitorsGUANGDONG NEWOPP BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted May 23, 2023·1 cites·6 claims
- 0246US2016361314A1Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseasesNOVARTIS AG·Filed 2014·Application pending·0 cites
- 0345US2022153741A1Heterocyclic compounds as inhibitors of kras g12cGUANGDONG NEWOPP BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0444US2018318305A1Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseasesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0543US2020085814A1Combination of certinib with an egfr inhibitorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0642US2025179017A1Carboxamide compounds as pge2 receptor antagonistsGUANGDONG NEWOPP BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0742US2020253978A1Heterocyclics as inhibitors of fibroblast growth factor receptorADVENT PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0833US2022251116A1Alkylboronic acids as arginase inhibitorsGUANGDONG NEWOPP BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0928US2017252335A1Combination of Ceritinib with an EGFR InhibitorPANTANO SERAFINO·Filed 2015·Application pending·0 cites
- 1024US8703787B2Methods of using ALK inhibitorsLI NANXIN·Filed 2012·Granted Apr 22, 2014·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Nanxin Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →